FDA approves new weight loss drug Zepbound

FDA approves new weight loss drug Zepbound

FDA approves new weight loss drug Zepbound – CBS News

Watch CBS News

The Food and Drug Administration has approved the diabetes drug Mounjaro, which will be marketed as a weight loss drug under the name Zepbound.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.

Source: cbsnews.com